![]() |
Volumn 67, Issue 3, 2016, Pages 344-346
|
Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INCLACUMAB;
PADGEM PROTEIN;
PLACEBO;
CARDIOVASCULAR AGENT;
MONOCLONAL ANTIBODY;
ANGIOCARDIOGRAPHY;
ARTERY DIAMETER;
BLOOD ANALYSIS;
CANADA;
CARDIOVASCULAR DISEASE;
CORONARY ARTERY BYPASS SURGERY;
DRUG EFFICACY;
DRUG TARGETING;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FOLLOW UP;
HEART MUSCLE INJURY;
HUMAN;
LETTER;
MULTICENTER STUDY (TOPIC);
NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
NONHUMAN;
OFF PUMP CORONARY SURGERY;
PERCUTANEOUS CORONARY INTERVENTION;
PHASE 1 CLINICAL TRIAL (TOPIC);
POST HOC ANALYSIS;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SAPHENOUS VEIN GRAFT;
TREATMENT DURATION;
TREATMENT OUTCOME;
UNITED STATES;
ACUTE CORONARY SYNDROME;
ADVERSE EFFECTS;
AGED;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ANGIOGRAPHY;
CORONARY ARTERY BYPASS GRAFT;
DOUBLE BLIND PROCEDURE;
FEMALE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
POSTOPERATIVE COMPLICATIONS;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL;
ACUTE CORONARY SYNDROME;
AGED;
ANTIBODIES, MONOCLONAL;
CARDIOVASCULAR AGENTS;
CORONARY ANGIOGRAPHY;
CORONARY ARTERY BYPASS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
P-SELECTIN;
POSTOPERATIVE COMPLICATIONS;
TREATMENT OUTCOME;
|
EID: 84957824881
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2015.10.071 Document Type: Letter |
Times cited : (35)
|
References (5)
|